Poolbeg Pharma plc

Drug Discovery

  • Funding stage: IPO
  • Technology type: Any
  • East Central London
Membership category
Corporate

40 Bank Street, Floor 24, London, E14 5NR, United Kingdom

Poolbeg Pharma plc at a glance

Poolbeg Pharma is a clinical-stage biopharmaceutical company focussed on the development of innovative medicines to address unmet medical needs

About Poolbeg Pharma plc

Poolbeg Pharma plc (AIM: POLB) is a clinical-stage biopharmaceutical company focussed on the development of innovative medicines to address unmet medical needs. The Company is led by a highly experienced management team with track record of building successful life science companies and generating shareholder returns.

Poolbeg’s clinical programmes target large addressable markets including cancer immunotherapy-induced Cytokine Release Syndrome (CRS) and metabolic conditions such as obesity with the development of an oral GLP-1R agonist. It uses a cost-effective development philosophy to generate high quality data to support partnering and further development. Its AI-led discovery programmes analyse unique data from human challenge trials to identify clinically relevant drug targets and treatments, leading to faster development and greater commercial appeal.

Therapeutic area(s)

Articles Poolbeg Pharma plc has contributed to